Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir Standard Dose versus Double Dose for Influenza A/H1N1 Resistance
2016-001044-18Phase 4
- Sponsor
- Roche
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oseltamivir in influenza A(H1N1)2009 (H1N1), influenza, sponsored by Roche.
02
Drugs
oseltamivir
03
Conditions
influenza A(H1N1)2009 (H1N1)influenza
Beyond the preview
Go deeper on 2016-001044-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001044-18.